Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals.

J Int Neuropsychol Soc. 1995 Nov;1(6):581-8. Unique Identifier : AIDSLINE MED/98042816
Bix BC; Glosser G; Holmes W; Ballas C; Meritz M; Hutelmyer C; Turner J; Department of Medicine, Graduate Hospital, Philadelphia, Pennsylvania; 19146, USA.


Abstract: Neuropsychological impairment and DSM-III-R Axis I psychiatric diagnoses were evaluated in a heterogenous group of HIV seropositive individuals and seronegative individuals with similar risk factors for HIV infection. Neuropsychological and psychiatric disorders were common in the HIV seropositive group, but there were no relationships between these two aspects of neuropsychiatric dysfunction in seropositive patients. Results indicate that psychiatric disorders in HIV seropositive individuals tend to predate infection and decrease over time following knowledge of seroconversion, suggesting that they are primarily a function of psychosocial factors. Neuropsychological disorders are specific to HIV seropositive patients and tend to increase over time following seroconversion, suggesting that they are due to neurological effects of HIV-infection.
Keywords: *AIDS Dementia Complex/DIAGNOSIS *HIV Seropositivity/DIAGNOSIS *Mental Disorders/DIAGNOSIS *Neuropsychological Tests/STATISTICS & NUMER DATAKWDaidsdementiacomplex/diagnosisKWDhivseropositivity/diagnosisKWDmentaldisorders/diagnosisKWDneuropsychologicaltests/statistics&numerdata
980330
M9831208

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .